Apotex Inc. v. Shire LLC, 2017 FC 831 (Lisdexamfetamine*)

Proth. Tabib - 2017-09-14

Read full decision. Automatically generated summary:

This motion arises in the context of an action brought by Apotex Inc. against Shire LLC and Shire Pharma Canada ULC for a declaration of non-infringement and of invalidity of Canadian Patent No. 2,027,646, entitled “Abuse Resistant Amphetamine Compounds”.

Decision relates to:


Canadian Intellectual Property